Viewing Study NCT05353166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2026-01-27 @ 11:01 PM
Study NCT ID: NCT05353166
Status: COMPLETED
Last Update Posted: 2025-06-11
First Post: 2022-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None New York Heart Association (NYHA) class II/III with symptoms of … View
None Elevated Pulmonary Capillary Wedge Pressure View
None Reduced Left Ventricular Ejection Fraction View